Latham & Watkins advised Marley Spoon on the deal, while Sullivan & Cromwell and Flick Gocke advised 468 SPAC II. 468 SPAC II SE, a publicly...
Marley Spoon’s Listing on Frankfurt Stock Exchange
Atlantic Park and GIC’s €550 Million investment in Cheplapharm
Latham & Watkins has advised CHEPLAPHARM AG on the deal. CHEPLAPHARM AG (CHEPLAPHARM), a leading international platform for well-established branded medicines, announced its agreement for a...
KKR’s Acquisition of Minority Stake in Körber’s Supply Chain Software Business
Latham & Watkins advised Körber in the transaction. Körber announced the sale of a substantial minority stake in its supply chain software business to KKR. The...
Majorel’s €660 Million Private Placement
Sullivan & Cromwell advised Majorel on the deal, while Latham & Watkins advised the syndicate of banks. Majorel, a leading global provider of call centers, completed...
Vitesco Technologies’ Spin-Off From Continental And Initial Public Offering
Schilling, Zutt & Anschütz has accompanied Vitesco Technologies Group AG in the transaction. Freshfields Bruckhaus Deringer advised Continental. Latham & Watkins advised the banks. Vitesco Technologies,...
SUSE’s €1.1 Billion Initial Public Offering
Latham & Watkins advised the consortium of banks on the IPO of SUSE S.A. on the Frankfurt Stock Exchange. In the course of the IPO, 37.3...
SUSE’s €1.1 Billion Initial Public Offering
Latham & Watkins advised the consortium of banks on the IPO of SUSE S.A. on the Frankfurt Stock Exchange. In the course of the IPO, 37.3...
Jumia Technologies’ $348.6 Million Capital Increase and “At the Market” Sales Offering
Latham & Watkins LLP has advised Citigroup Global Markets Inc. on the deal. Jumia Technologies AG (Jumia), the leading pan-African e-commerce platform listed on the New...
Siemens Healthineers’ €2.34 Billion Capital Increase
Latham & Watkins LLP advised Siemens Healthineers AG on the deal. Siemens Healthineers AG (Siemens Healthineers) completed a further capital increase with gross proceeds of around...